NCT06949462

Brief Summary

Patient understanding of anaesthesia risks remains inconsistent due to time constraints, language barriers, and variable clinician communication styles. Traditional verbal consent may not consistently ensure comprehension or reduce preoperative anxiety. PEAR (Patient Education of Anesthesia Risks) is a multilingual, AI-driven chatbot developed to enhance patient education and improve the quality of anaesthesia risk counselling. Study Objective: To compare PEAR's performance in delivering anaesthesia risk consent against the standard face-to-face verbal method.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 22, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 29, 2025

Completed
8 months until next milestone

Study Start

First participant enrolled

January 7, 2026

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 27, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 27, 2026

Completed
Last Updated

May 7, 2026

Status Verified

April 1, 2026

Enrollment Period

4 months

First QC Date

April 22, 2025

Last Update Submit

April 30, 2026

Conditions

Keywords

AnaesthesiaInformed ConsentLarge Language ModelArtificial Intelligence

Outcome Measures

Primary Outcomes (1)

  • Patient self-reported understanding of anaesthesia risks

    The primary outcome was assessed using a Patient-Reported Experience Measure (PREM) focused on subjective comprehension of anesthesia. This was measured via three validated 5-point Likert scale items (1 = strongly disagree, 5 = strongly agree) evaluating: (1) clarity of risks and procedures, (2) confidence in the anesthesia plan, and (3) self-reported ability to recall and explain key risks. While both groups completed these items following the clinician consultation, the intervention group underwent additional longitudinal assessments-at baseline and post-chatbot interaction-to facilitate a within-group analysis of the chatbot's independent educational impact.

    Immediately post-interaction with the PEAR Chatbot

Secondary Outcomes (5)

  • Perceived Usefulness

    Immediately pre-consent and post-consent (within the same clinic visit)

  • Cost effectiveness

    Immediately post-chatbot use (same clinic visit)

  • Perceived Ease of Use (PEOU)

    Immediately pre-consent and immediately post-consent (within the same clinic visit).

  • Attitude Toward Using (ATT)

    Immediately pre-consent and immediately post-consent (within the same clinic visit).

  • Behavioral Intention to Use (BI)

    Immediately pre-consent and immediately post-consent (within the same clinic visit).

Study Arms (2)

Control

NO INTERVENTION

Participants in the control arm will receive the standard anaesthesia risk counselling conducted face-to-face by a licensed anaesthetist. This process follows institutional protocols and includes a verbal explanation of anaesthesia procedures, associated risks, benefits, and potential complications, tailored to the patient's specific surgical context. Patients are encouraged to ask questions and engage in discussion during the session. No digital tools or chatbot assistance will be used in this arm.

PEAR

EXPERIMENTAL

Participants in this arm will receive anaesthesia risk counselling through the PEAR (Patient Education of Anaesthesia Risks) chatbot, a multilingual, AI-powered conversational tool. The chatbot provides personalized education on anaesthesia risks, procedures, and post-operative expectations. Patients interact with the chatbot prior to meeting the anaesthetist, enhancing their understanding and preparing them for the face-to-face consultation.

Other: PEAR

Interventions

PEAROTHER

Participants in the intervention arm will receive anaesthesia risk counselling through the PEAR (Patient Education of Anaesthesia Risks) chatbot prior to their face-to-face consultation with an anaesthetist. PEAR is a multilingual, AI-powered conversational tool designed to provide personalized, interactive education on anaesthesia-related procedures, risks, and safety information. The chatbot delivers content aligned with institutional guidelines and allows patients to explore topics at their own pace, ask questions in natural language, and revisit information as needed. After completing the chatbot interaction, patients proceed with their standard preoperative consultation, where any further questions are addressed by the anaesthetist. This approach is designed to enhance patient understanding, reduce anxiety, and optimize the in-person consultation by preparing patients in advance.

PEAR

Eligibility Criteria

Age21 Years - 99 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \- Adults (≥21 years old) undergoing elective surgery requiring anaesthesia
  • Classified as ASA Physical Status I to III
  • Able to provide informed consent
  • Able to communicate effectively in English, Chinese (Mandarin), Malay, or Tamil
  • Willing and able to complete questionnaires and interact with the PEAR chatbot (intervention arm)

You may not qualify if:

  • ASA Physical Status IV or above
  • Cognitive impairment or psychiatric conditions that may limit comprehension or communication
  • Non-literate patients or those unable to understand English, Chinese, Malay, or Tamil
  • Emergency surgery cases
  • Prior participation in the study (to prevent bias)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Singapore General Hospital

Singapore, Singapore, 249094, Singapore

RECRUITING

Singapore General Hospital

Singapore, Singapore, 751126, Singapore

NOT YET RECRUITING

Related Publications (1)

  • Ke YH, Jin L, Elangovan K, Abdullah HR, Liu N, Sia ATH, Soh CR, Tung JYM, Ong JCL, Kuo CF, Wu SC, Kovacheva VP, Ting DSW. Retrieval augmented generation for 10 large language models and its generalizability in assessing medical fitness. NPJ Digit Med. 2025 Apr 5;8(1):187. doi: 10.1038/s41746-025-01519-z.

    PMID: 40185842BACKGROUND

Central Study Contacts

Yuhe Ke, MMED (ANES)

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
There will be no blinding of the participants and investigators due to the impracticality. The outcome assessor will be blinded.
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: This study uses a parallel-group, randomized controlled trial (RCT) design to evaluate the effectiveness of PEAR, a conversational AI chatbot for anaesthesia risk counselling. Participants are randomly assigned in a 1:1 allocation ratio to one of two arms: Intervention Group: Receives anaesthesia risk information through the PEAR chatbot prior to their consultation with an anaesthetist. Control Group: Receives anaesthesia counselling through the standard, face-to-face verbal consent process by a clinician. Randomisation is stratified by surgical specialty to ensure balanced representation across different clinical settings.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Consultant

Study Record Dates

First Submitted

April 22, 2025

First Posted

April 29, 2025

Study Start

January 7, 2026

Primary Completion

April 27, 2026

Study Completion

April 27, 2026

Last Updated

May 7, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will share

De-identified individual participant data (IPD) that underlie the results reported in the publication (including primary and secondary outcomes, baseline characteristics, and questionnaire scores) will be made available to qualified researchers upon reasonable request. Data will be shared beginning 6 months after publication and will be accessible for up to 3 years post-publication. Requests must include a methodologically sound proposal and be submitted to the Principal Investigator. A data access agreement will be required to ensure ethical use and protection of participant confidentiality.

Shared Documents
ANALYTIC CODE
Time Frame
1st July 2025 - 1st july 2028
Access Criteria
Access to de-identified individual participant data (IPD) will be granted to qualified academic researchers, healthcare professionals, or institutions conducting methodologically sound research that aligns with ethical standards and scientific purpose.

Locations